Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative
ConclusionWhile signet cells are a negative prognostic feature, they should not be a contraindication to CRS-HIPEC in patients with well-moderately differentiated tumors with negative lymph nodes, where complete cytoreduction can be achieved.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
More News: Adenocarcinoma | Cancer & Oncology | Carcinoma | Chemotherapy | Databases & Libraries | Gastroenterology | Peritoneal Cancer | Study | Surgery